|Articles|January 31, 2022
DFE Pharma offers starch-based excipients for nutraceuticals
Author(s)Jennifer Grebow
The excipients are naturally sourced and multifunctional as binders, fillers, and disintegrants for oral solid dosage forms.
Advertisement
DFE Pharma (Goch, Germany) has launched its Nutroféli line of starch-based excipients for nutraceuticals. The excipients are naturally sourced and multifunctional as binders, fillers, and disintegrants for oral solid dosage forms.
The Nutroféli line includes a native starch excipient (Nutroféli ST100), a partially pregelatinized starch (Nutroféli ST200), and a fully gelatinized starch (Nutroféli ST300).
The starches comply with clean-label requirements and both food and pharmaceutical monographs, the company says.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Nutritional Outlook - Supplement, Food & Beverage Manufacturing Trends
1
A New Frontier in Eye Health: Digital Wellness, Bioavailability, and the Eye-Brain Connection
2
Clasado Biosciences Partners with Prokopton SAS to Expand Bimuno GOS Distribution in France
3
Finished Product Clinical Validation Emerges as a Competitive Differentiator in the Supplement Industry
4
Lion’s Mane Ingredient Targets Standardized Erinacine A
5